Influence of serum total cholesterol, LDL, HDL, and triglyceride on prostate cancer recurrence after radical prostatectomy

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.2125425559415
   PubMed Web of Science ®Google Scholar
• Faria EF, Chapin BF, Muller RL, Machado RD, Reis RB, Matin SF. Radical prostatectomy for locally advanced prostate cancer: current status. Urology. 2015;86(1):10–15. doi:10.1016/j.urology.2015.03.01226048432
   PubMed Web of Science ®Google Scholar
• Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294(4):433–439. doi:10.1001/jama.294.4.43316046649
   PubMed Web of Science ®Google Scholar
• Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172(3):910–914. doi:10.1097/01.ju.0000134888.22332.bb15310996
   PubMed Web of Science ®Google Scholar
• Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol. 2007;51(5):1175–1184. doi:10.1016/j.eururo.2007.01.01517240528
   PubMed Web of Science ®Google Scholar
• Han M, Partin AW, Zahurak M, Piantadosi S, Epstein JI, Walsh PC. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol. 2003;169(2):517–523. doi:10.1097/01.ju.0000045749.90353.c712544300
   PubMed Web of Science ®Google Scholar
• Sempos CT, Cleeman JI, Carroll MD, et al. Prevalence of high blood cholesterol among US adults. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA. 1993;269(23):3009–3014.8501843
   PubMed Web of Science ®Google Scholar
• Krycer JR, Brown AJ. Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim Biophys Acta. 2013;1835(2):219–229. doi:10.1016/j.bbcan.2013.01.00223357067
   PubMed Web of Science ®Google Scholar
• Allott EH, Howard LE, Aronson WJ, et al. Racial differences in the association between preoperative serum cholesterol and prostate cancer recurrence: results from the SEARCH database. Cancer Epidemiol Biomarkers Prev. 2016;25(3):547–554. doi:10.1158/1055-9965.EPI-15-087626809276
   PubMed Web of Science ®Google Scholar
• Macleod LC, Chery LJ, Hu EY, et al. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort. Prostate Cancer Prostatic Dis. 2015;18(2):190–195. doi:10.1038/pcan.2015.1225823651
   PubMed Web of Science ®Google Scholar
• Sanchis-Bonet A, Ortiz-Vico F, Morales-Palacios N, Sanchez-Chapado M. The association between metabolic syndrome and prostate cancer: effect on its aggressiveness and progression. Actas Urol Esp. 2015;39(3):154–160. doi:10.1016/j.acuro.2014.09.00925454266
   PubMed Web of Science ®Google Scholar
• Komaru A, Kamiya N, Suzuki H, et al. Implications of body mass index in Japanese patients with prostate cancer who had undergone radical prostatectomy. Jpn J Clin Oncol. 2010;40(4):353–359. doi:10.1093/jjco/hyp16420064824
   PubMed Web of Science ®Google Scholar
• Kang M, Jeong CW, Ku JH, Kwak C, Kim HH. Hypertriglyceridemia is a potential preoperative predictor for biochemical recurrence after radical prostatectomy. PLoS One. 2015;10(3):e0122438. doi:10.1371/journal.pone.012243825803284
   PubMed Web of Science ®Google Scholar
• Rantaniemi L, Tammela TLJ, Kujala P, Murtola TJ. Blood cholesterol, tumor clinical characteristics and risk of prostate cancer progression after radical prostatectomy. Scand J Urol. 2018;52(4):269–276. doi:10.1080/21681805.2018.149296730362865
   PubMed Web of Science ®Google Scholar
• Wettstein MS, Saba K, Umbehr MH, et al. Prognostic role of preoperative serum lipid levels in patients undergoing radical prostatectomy for clinically localized prostate cancer. Prostate. 2017;77(5):549–556. doi:10.1002/pros.2329628093792
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W264. doi:10.7326/0003-4819-151-4-200908180-0013519622511
   PubMed Web of Science ®Google Scholar
• Ohno Y, Ohori M, Nakashima J, et al. Association between preoperative serum total cholesterol level and biochemical recurrence in prostate cancer patients who underwent radical prostatectomy. Mol Clin Oncol. 2016;4(6):1073–1077. doi:10.3892/mco.2016.83127284447
   PubMedGoogle Scholar
• Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17(24):2815–2834.9921604
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.3802833
   PubMedGoogle Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.7786990
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:10.1136/bmj.315.7109.6299310563
   PubMed Web of Science ®Google Scholar
• Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455–463.10877304
   PubMed Web of Science ®Google Scholar
• Allott EH, Farnan L, Steck SE, et al. Statin use, high cholesterol and prostate cancer progression; results from HCaP-NC. Prostate. 2018;78(11):857–864. doi:10.1002/pros.2364429717502
   PubMed Web of Science ®Google Scholar
• Bhindi B, Xie WY, Kulkarni GS, et al. Influence of metabolic syndrome on prostate cancer stage, grade, and overall recurrence risk in men undergoing radical prostatectomy. Urology. 2016;93:77–85. doi:10.1016/j.urology.2016.01.04127015944
   PubMed Web of Science ®Google Scholar
• Shiota M, Yokomizo A, Takeuchi A, et al. The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy. J Surg Oncol. 2014;110(4):476–481. doi:10.1002/jso.2367724898352
   PubMed Web of Science ®Google Scholar
• Post JM, Beebe-Dimmer JL, Morgenstern H, et al. The metabolic syndrome and biochemical recurrence following radical prostatectomy. Prostate Cancer. 2011;2011:245642. doi:10.1155/2011/24564222096652
   PubMedGoogle Scholar
• Zhuang L, Lin J, Lu ML, Solomon KR, Freeman MR. Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. Cancer Res. 2002;62(8):2227–2231.11956073
   PubMed Web of Science ®Google Scholar
• Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery RB. Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PLoS One. 2012;7(1):e30062. doi:10.1371/journal.pone.003006222279565
   PubMed Web of Science ®Google Scholar
• Murtola TJ, Syvala H, Pennanen P, et al. The importance of LDL and cholesterol metabolism for prostate epithelial cell growth. PLoS One. 2012;7(6):e39445. doi:10.1371/journal.pone.003944522761797
   PubMed Web of Science ®Google Scholar
• Lin X, Lu L, Liu L, et al. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. J Clin Lipidol. 2017;11(4):1073–1081. doi:10.1016/j.jacl.2017.05.00428669687
   PubMed Web of Science ®Google Scholar
• Touvier M, Fassier P, His M, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 2015;114(3):347–357. doi:10.1017/S000711451500183X26173770
   PubMed Web of Science ®Google Scholar
• Zhou P, Li B, Liu B, Chen T, Xiao J. Prognostic role of serum total cholesterol and high-density lipoprotein cholesterol in cancer survivors: a systematic review and meta-analysis. Clin Chim Acta. 2018;477:94–104. doi:10.1016/j.cca.2017.11.03929223765
   PubMed Web of Science ®Google Scholar
• Ma HQ, Cui LH, Li CC, Yu Z, Piao JM. effects of serum triglycerides on prostate cancer and breast cancer risk: a meta-analysis of prospective studies. Nutr Cancer. 2016;68(7):1073–1082. doi:10.1080/01635581.2016.120658227618148
   PubMed Web of Science ®Google Scholar
• YuPeng L, YuXue Z, PengFei L, et al. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24(7):1086–1093. doi:10.1158/1055-9965.EPI-14-132925953767
   PubMed Web of Science ®Google Scholar